<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>AK-CON- naphazoline hydrochlorideÂ solutionÂ </strong><br>Rebel Distributors Corp.<br></p></div>
<h1>ALBALON<span class="Sup">Â®</span><br>(naphazoline hydrochloride ophthalmic solution, USP) 0.1%</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_bbd2cb9e-1dcc-403a-8b86-d0cbf2a20c52"></a><a name="section-1"></a><p></p>
<p class="First">Sterile</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_d7f45a8a-744a-40e6-ae13-83da2272a5b3"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Naphazoline hydrochloride, an ocular vasoconstrictor, is an imidazoline derivative sympathomimetic amine. It occurs as a white, odorless crystalline powder having a bitter taste and is freely soluble in water and in alcohol. The active ingredient is represented by the structural formula:</p>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=297f0888-729c-4ce6-8779-6b239abf3c93&amp;name=297f0888-729c-4ce6-8779-6b239abf3c93-01.jpg"></div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_6db86ef6-90a9-457d-8cff-5665e672253b"></a><a name="section-2.1"></a><p></p>
<h2>Chemical Name:</h2>
<p class="First">2-(1-Naphthylmethyl)-2-imidazoline monohydrochloride</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_097dbead-3227-4a4b-a2d4-7a131f33345b"></a><a name="section-2.1.1"></a><p></p>
<h3>Contains:</h3>
<p class="First"><span class="Bold">Active:</span> naphazoline HCl 1 mg (0.1%). <span class="Bold">Preservative:</span> benzalkonium chloride 0.1mg (0.01%). <br><span class="Bold">Inactives:</span> Boric acid; edetate disodium; purified water; sodium chloride; sodium carbonate; and  hydrochloric acid may be added to adjust the pH (5.5 to 7.0).</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_28f482ce-db7f-42a8-a44d-cdbacd7f50a6"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Naphazoline constricts the vascular system of the conjunctiva. It is presumed that this effect is due to direct stimulation of the drug upon the alpha-adrenergic receptors in the arterioles of the conjunctiva, resulting in decreased <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival congestion</span>. Naphazoline belongs to the imidazoline class of sympathomimetics.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_c7ffc376-d079-45f0-aa6e-13e2c0d02e15"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Naphazoline Hydrochloride Ophthalmic Solution is indicated for use as a topical ocular vasoconstrictor.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_0147d2ad-16a3-4974-8c15-b6bf728390be"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Contraindicated in the presence of an anatomically narrow angle or in narrow-angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> or in persons who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component of this preparation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_9306dba4-9d26-4b85-a104-78def8fe2ed0"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Patients under therapy with MAO inhibitors may experience a severe <span class="product-label-link" type="condition" conceptid="312938" conceptname="Hypertensive encephalopathy">hypertensive crisis</span> if given a sympathomimetic drug. Use in children, especially infants, may result in <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> leading to <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span> and marked reduction in body temperature.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_b24534f6-b747-4924-a7fd-82675132895a"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_f1da7015-1402-4f8c-9ab0-e5762f45831a"></a><a name="section-7.1"></a><p></p>
<h2>General:</h2>
<p class="First">For topical ophthalmic use only. Use with caution in the presence of <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, cardiovascular abnormalities, <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span> (<span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>), <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> or injury.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_80e605d4-794d-4879-ac47-77d0b6528ddc"></a><a name="section-7.2"></a><p></p>
<h2>Patient Information:</h2>
<p class="First">Patients should be advised to discontinue the drug and consult a physician if relief is not obtained within 48 hours of therapy, if irritation, blurring or <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> persists or increases, or if symptoms of systemic absorption occur, i.e., <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, decrease in body temperature, or <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>.</p>
<p>To prevent contaminating the dropper tip and solution, do not touch the eyelids or the surrounding area with the dropper tip of the bottle. If solution changes color or becomes cloudy, do not use.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_72f37812-633e-441a-a0dd-71c3cf20d9b2"></a><a name="section-7.3"></a><p></p>
<h2>Drug Interactions:</h2>
<p class="First">Concurrent use of maprotiline or tricyclic antidepressants and naphazoline may potentiate the pressor effect of naphazoline. Patients under therapy with MAO inhibitors may experience a severe <span class="product-label-link" type="condition" conceptid="312938" conceptname="Hypertensive encephalopathy">hypertensive crisis</span> if given a sympathomimetic drug. (See <a href="#i4i_warnings_id_9306dba4-9d26-4b85-a104-78def8fe2ed0">WARNINGS.</a>)</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_77c82cc6-f995-468d-a03b-ab8a739c2a29"></a><a name="section-7.4"></a><p></p>
<h2>Pregnancy:</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_4bc678a8-f2d4-4045-9017-4844d0b1d8d9"></a><a name="section-7.4.1"></a><p></p>
<p class="First"><span class="Bold">Pregnancy Category C:</span> Animal reproduction studies have not been <br>conducted with naphazoline. It is also not known whether naphazoline can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Naphazoline should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_60d0441d-0fdd-43d5-8fb3-31db468bac23"></a><a name="section-7.5"></a><p></p>
<h2>Nursing Mothers:</h2>
<p class="First">It is not known whether naphazoline is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when naphazoline is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_1e059ac0-e1c2-4b07-81a5-29393f54ec16"></a><a name="section-7.6"></a><p></p>
<h2>Pediatric Use:</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established. See â€œ<a href="#i4i_warnings_id_9306dba4-9d26-4b85-a104-78def8fe2ed0">WARNINGS.</a>â€? and â€œ<a href="#i4i_contraindications_id_0147d2ad-16a3-4974-8c15-b6bf728390be">CONTRAINDICATIONS.</a>â€?</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_37ad31af-fc43-4276-a34d-b937bc1be71a"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_e4577a11-59ce-42c6-959b-518325458335"></a><a name="section-8.1"></a><p></p>
<p class="First"><span class="Bold">Ocular:</span> <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">Mydriasis</span>, increased <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, irritation, <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span>, blurring, <span class="product-label-link" type="condition" conceptid="375265" conceptname="Punctate keratitis">punctate keratitis</span>, <span class="product-label-link" type="condition" conceptid="435553" conceptname="Epiphora">lacrimation</span>, <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_247ded24-2caa-4a2c-ba1b-ec8a63b5f8ed"></a><a name="section-8.2"></a><p></p>
<p class="First"><span class="Bold">Systemic:</span> <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span> , <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, cardiac irregularities, and <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_2bf82b76-781c-4ff2-a1fe-8f0d9c9569a6"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Instill one or two drops in the conjunctival sac(s) every three to four hours as needed.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_bf99d29d-a341-4d1f-a1a8-c80cec2aab1a"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Naphazoline Hydrochloride Ophthalmic Solution, USP) is supplied as a sterile 0.1% solution in </p>
<p>Â Â Â Â Â Â 15 mL plastic dropper bottles. <span class="Bold">NDC</span> 17478-216-12</p>
<p><span class="Bold">Storage:</span> Store at 20Â° to 25Â°C (68Â° to 77Â°F). Keep container tightly closed.</p>
<p><span class="Bold">Rx Only</span></p>
<p>Manufactured by: </p>
<p>Akorn Inc.<br>Lake Forest, IL 60045</p>
<p>Repackaged by:</p>
<p>Rebel Distributors Corp</p>
<p>Thousand Oaks, CA 91320</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_985dcb2a-2f7a-4f9c-9a92-fbb4f0bcf2ca"></a><a name="section-11"></a><p></p>
<h1>Principal Display Panel</h1>
<p class="First"><img alt="AK-Con 0.1%" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=297f0888-729c-4ce6-8779-6b239abf3c93&amp;name=297f0888-729c-4ce6-8779-6b239abf3c93-02.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>AK-CONÂ 		
					</strong><br><span class="contentTableReg">naphazoline hydrochloride solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:21695-915(NDC:17478-216)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>naphazoline hydrochloride</strong> (naphazoline) </td>
<td class="formItem">naphazoline hydrochloride</td>
<td class="formItem">1Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>edetate disodium</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>water</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium chloride</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CARBONATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BORIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:21695-915-15</td>
<td class="formItem">15 mL in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA083590</td>
<td class="formItem">08/22/1974</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Rebel Distributors Corp.
							(118802834)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Rebel Distributors Corp.</td>
<td class="formItem"></td>
<td class="formItem">118802834</td>
<td class="formItem">RELABEL, REPACK</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 3/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>297f0888-729c-4ce6-8779-6b239abf3c93</div>
<div>Set id: 297f0888-729c-4ce6-8779-6b239abf3c93</div>
<div>Version: 1</div>
<div>Effective Time: 20110330</div>
</div>
</div>Â <div class="DistributorName">Rebel Distributors Corp.</div></p>
</body></html>
